Status:
COMPLETED
Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe
Lead Sponsor:
AHS Cancer Control Alberta
Collaborating Sponsors:
Cross Cancer Institute
Conditions:
Healthy
Eligibility:
MALE
18+ years
Brief Summary
This study performed a retrospective analysis of patient images to develop software in determining dose delivered for each fraction treatment.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Subject 18 years of age and over
Exclusion
Key Trial Info
Start Date :
September 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2006
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT00314522
Start Date
September 1 2005
End Date
March 1 2006
Last Update
February 25 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2